INMB vs WAT · rev $50.0K vs P/E 32, rev $3.17B
INmune Bio Inc (INMB) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
Latest reported WAT revenue for 2025-12-31 was $3.17B. Net income was $642.6M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
INMB currently screens at market cap $33.5M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the INMB and WAT stock pages for the full models.
Not investment advice.